Managing the Atopic Dog: Clinical Insights for Every Practitioner
2026-07-08 19:00 - 21:00 UTC | NY
Managing the Atopic Dog: Clinical Insights for Every Practitioner
This program will provide veterinary practitioners with an updated, evidence-based overview of the pathophysiology of canine atopic dermatitis (cAD), highlighting the complex immunologic and barrier dysfunction mechanisms underlying the disease. Review of broad treatment strategies—ranging from allergen avoidance, topical therapies (not discussed in detail during this session) to systemic immunomodulation. Treatment goals will be discussed in the context of acute symptom relief, long-term disease control, and improvement in patient well-being. Special focus will be placed on Janus kinase inhibitors (JAKi), including an in-depth discussion of Zenrelia. Comparative insights into mechanism of action, clinical efficacy, safety, and patient selection will be presented to help veterinarians make informed decisions in daily practice. By the conclusion of this session, attendees will be equipped with practical knowledge to optimize outcomes for dogs with atopic dermatitis through tailored, mechanism-driven treatment plans.
Learning Objectives:

Gain a clearer understanding of the underlying drivers of canine atopic dermatitis, including immune and skin barrier dysfunction.
Explore practical treatment strategies that balance rapid itch relief with sustainable, long-term disease control.
Learn how Janus kinase inhibitors fit into modern dermatology protocols, including when and how to use them safely and effectively.
Walk away with actionable, patient-focused approaches you can apply immediately to improve outcomes in atopic dogs.

Speaker: Andrew Rosenberg DVM, DACVD
Dr. Andrew Rosenberg is a board-certified veterinary dermatologist and a leader in the field of veterinary dermatology. He earned his Bachelor of Science with distinction in research from Cornell University in 2005 and received his Doctor of Veterinary Medicine from the Cornell University College of Veterinary Medicine in 2009.
Dr. Rosenberg completed a three-year dermatology residency with Animal Dermatology Clinic and achieved Diplomate status with the American College of Veterinary Dermatology (ACVD) in 2013. He was the founder and owner of Animal Dermatology & Allergy Specialists, with multiple locations across New York and New Jersey. In 2022, he rejoined the Animal Dermatology Group—the largest veterinary dermatology network in the world—where he currently practices in Wayne, NJ, and White Plains, NY. He also serves as the group’s Director of Medical Operations.
Dr. Rosenberg is the current President of the American College of Veterinary Dermatology. He is a sought-after speaker and educator, known for delivering lectures that are rooted in current science but focused on practical application for everyday clinical practice. He has published widely and serves on multiple advisory boards.
Dr. Rosenberg also has a strong interest in exotic animal dermatology and collaborates with zoos on dermatologic care. His expertise has been featured on Animal Planet’s The Zoo and in numerous podcasts and radio programs.

Big Apple Summer Veterinary Mixer
2026-07-16 19:00 - 22:00 (America/New_York) | Castell Rooftop Lounge, 260 West 40th Street, New York, NY, 10018

Executive Board Meeting
2026-09-09 16:30 - 18:30 UTC | Empire Steak House West, 237 West 54th Street, New York, NY, 10019

Supplements in Cancer Care + Everyday Practice: What to Use, When, and Why / Oncology in Everyday Practice: Yes, You Can!
2026-09-09 19:00 - 21:00 (America/New_York) | Empire Steak House West, 237 West 54th Street, New York, NY, 10019
Supplements in Cancer Care + Everyday Practice: What to Use, When, and Why
Supplements come up in nearly every cancer conversation – and in plenty of everyday cases, too. This practical, evidence-informed session helps general practitioners confidently choose and use a short list of high-yield supplements in practice. We’ll focus on probiotics/synbiotics, sulforaphane, omega-3 fatty acids, and SAMe – when to reach for each, how to dose them, and what the research actually supports, including how to use them alongside common treatments. You’ll leave with practical dosing starting points, product selection tips, and real-world pearls you can use right away. You’ll see how these supplements fit into everyday cases across general practice, not just cancer care.
Learning Objectives:

Review the integration of key supplements such as probiotics, omega-3 fatty acids, SAMe, and sulforaphane into both cancer-specific and general health treatment plans.
Demonstrate the practical implementation of these supplements across a variety of clinical settings, ensuring safe and effective usage.
Examine the latest research and clinical evidence supporting the use of these supplements, alongside traditional cancer therapies and their potential benefits beyond oncology.
Optimize patient care strategies by incorporating supplements into comprehensive treatment protocols that improve outcomes and enhance quality of life.

Oncology in Everyday Practice: Yes, You Can!
Cancer cases can be challenging in general practice but with the right tools and a practical approach, many can be managed successfully in-house. In this case-based session, we’ll walk through real-world oncology scenarios GPs encounter regularly. From deciding which mast cell tumor cases are appropriate for Stelfonta® to managing canine lymphoma with Laverdia® when referral isn’t an option and exploring non-IV chemotherapy choices for feline lymphoma, this session offers actionable guidance for confident care. You’ll leave with tips you can implement immediately and the confidence to take on more oncology cases in your clinic.
Learning Objectives:

Discuss treatment options for mast cell tumors in general practice, including when to consider surgery versus Stelfonta®, and how to decide which cases to manage in-clinic versus refer—especially when starting out with Stelfonta®.
Compare oral chemotherapy options for canine lymphoma, including Laverdia® and lomustine, and identify practical strategies for treatment in general practice.
Offer oral alternatives to intravenous chemotherapy for feline lymphoma cases when clients decline referral or traditional protocols.

Speaker: Sue Ettinger DVM, Diplomate ACVIM (Oncology)
Sue Ettinger, DVM, DACVIM (Oncology), widely recognized as Dr. Sue Cancer Vet®, brings over two decades of expertise in veterinary oncology to her position at Guardian Veterinary Specialists in Brewster, New York. She is among the 500 board-certified medical oncologists in North America. Her comprehensive training was completed at the Animal Medical Center in New York City.
Dr. Ettinger is not only a seasoned clinician but also a 2019 Western Veterinary Conference Small Animal Continuing Educator of the Year. She is a well-regarded speaker internationally, an author, and a staunch advocate for cancer awareness with her initiative, “See Something, Do Something, Why Wait? Aspirate.®”, aimed at promoting early detection of cancer.
On social media, Dr. Sue connects with a wide audience, including 55,000 followers on Instagram, 47,000 on Facebook, and 25,000 on YouTube, providing valuable information and support to pet owners and fellow veterinary professionals.
Beyond her professional life, Dr. Sue enjoys being a mother to two teenage boys and spending quality time with her energetic yellow Labrador, Penelope. An enthusiast of running and traveling, she finds joy in travel, especially to tropical beach destinations where she can unwind and recharge.
Sponsor:

Executive Board Meeting
2026-10-14 16:30 - 18:30 UTC | Arno’s Ristorante, 141 West 38th Street, New York, NY, 10018

The Wonderful World of Cannabinoids in Small Animal Practice
2026-10-14 19:00 - 21:00 (America/New_York) | Arno’s Ristorante, 141 West 38th Street, New York, NY, 10018
The Wonderful World of Cannabinoids in Small Animal Practice
This session will discuss what veterinarians should be looking for when recommending CBD- rich hemp-based products. The focus will be on the information that the veterinarian should be looking for on a certificate of analysis (COA) of marketed products. Discussion around the cannabinoid analysis when companies do third party testing, as well as microbiologics, mycotoxins, solvent residues, heavy metals, pesticides and terpenes will be covered. More importantly understanding if companies have validated utility of the product through pharmacokinetic testing in the species intended, as well as safety data with a deeper examination of current safety data around long-term supplementation. As there is increasing evidence on the efficacy of CBD rich hemp products on a variety of conditions these studies will be examined surrounding the growing evidence for chronic osteoarthritis pain, with further foray into acute surgical pain studies. Further evidence-based medicine will be examined around the growing number of trials surrounding seizures with a focus not only on efficacy, but potential drug interactions. Lastly, evidence around pruritic diseases and the immune system will be examined particularly around the atopic dermatitis, and cannabinoids as potential immune system regulators.
Learning objectives:

Learn how to read a common certificate of analysis.
Learn the rare adverse events associated with use of CBD hemp products and safely of long-term application.
Examine the pharmacokinetics and pharmacodynamics of CBD rich hemp application for proper dosing in dogs and cats.
Understand the differences in dosing and recommendations for acute versus chronic pain management
Provide insights into how to best apply CBD rich hemp in seizure management as an adjunctive nutraceutical during tradition treatment regimens.
Gain a better understanding of its use as an anti-pruritic approach to skin disease rather than as a immune system regulator.

Speaker: Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR
Joseph Wakshlag, DVM, PhD, DACVIM (Nutrition), DACVSMR received his Bachelors and Master of Science degrees from Montclair State College from his home state of NJ. He then attended Cornell University College of Veterinary Medicine for his Doctorate in Veterinary Medicine and then began an Anatomic Pathology residency after graduation in 1998. His passion for nutrition led to his non-traditional Veterinary Nutrition residency during his time at Cornell, as well as a PhD in pharmacology in 2005. Prior to this he did locum work in the Finger Lakes area and went into General Practice in Connecticut from 2005-2006 before returning to Cornell as an Assistant Professor on Nutrition at the College of Veterinary Medicine. During this time he rose through the ranks to become a Full Professor in 2018 while also becoming a founding member of the American College of Veterinary Sports Medicine and Rehabilitation, not only serving on the Board from 2010-2014, but also helped lead the American College of Veterinary Nutrition during a similar time frame.
Dr. Joe has been service Chief of Service for the Nutrition Department at Cornell since 2007 and was Chief of Service of the Sports Medicine and Rehabilitation department from 2014-2018. He has been very active in benchtop and clinical studies at Cornell in the areas of obesity, cancer cell biology, nutraceuticals, sporting dog metabolism and nutrient requirements. He has authored over a dozen book chapters and well over 100 peer reviewed publications and is a perennial speaker at VMX and WVC on the cannabinoids in veterinary medicine which has been a research focus of his over the last 5 years.
Sponsor:

Fall Mixer
2026-10-28 18:00 - 21:00 UTC | NY

NYVET Show
2026-10-29 08:00 - 2026-10-30 17:00 UTC | Jacob Javits Convention Center, 429 Eleventh Avenue, New York, NY, 10001

Executive Board Meeting
2026-11-02 16:30 - 18:30, 2026-12-01 16:00 - 18:00 UTC | NY

Continuing Education
2026-12-01 18:00 - 20:00 (America/New_York) | NY

Holiday Party
2026-12-01 20:00 - 23:00 UTC | NY
